FAMILIAL AGGREGATION OF MALIGNANT LYMPHOMAS
- Authors: Zvyagintseva D.1, Semiglazova T.1,2, Filatova L.1, Kurochkina D.1, Artemyeva A.1, Kuleva S.1,3
-
Affiliations:
- N.N. Petrov Research Institute of Oncology
- I.I. Mechnikov North-Western State Medical University
- Saint Petersburg State Pediatric Medical University
- Issue: Vol 26, No 11 (2015)
- Pages: 45-49
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116422
- ID: 116422
Cite item
Abstract
Full Text
About the authors
D. Zvyagintseva
N.N. Petrov Research Institute of Oncology
T. Semiglazova
N.N. Petrov Research Institute of Oncology; I.I. Mechnikov North-Western State Medical University
L. Filatova
N.N. Petrov Research Institute of Oncology
D. Kurochkina
N.N. Petrov Research Institute of Oncology
A. Artemyeva
N.N. Petrov Research Institute of Oncology
S. Kuleva
N.N. Petrov Research Institute of Oncology; Saint Petersburg State Pediatric Medical University
References
- Беляев А.М., Мерабишвили В.М. Злокачественные новообразования в Северо-Западном федеральном округе. 2-й вып. / СПб, 2015.
- Имянитов Е.Н., Хансон К.П. Эпидемиология и биология неходжкинских лимфом // Практическая онкология. - 2004; 5 (3): 163.
- Бобынцева О.В., Болдинова Е.О., Иванов В.П. и др. Анализ уровня спонтанного мутагенезана разных стадиях злокачественных лимфом // Applied and fundamental research. - 2015; 1: 76-9.
- de Haan L., Loves S., Daenen S. Familial Aggregation of Non-Hodgkin’s Lymphoma (NHL) // A Case Report, Hereditary Cancer in Clinical Practice. - 2006; 4 (3): 136-9.
- Adler B., Barchana M., Ben Yehuda D. et al. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma // Cancer. - 2000; 88: 2357-66.
- Adami H., Chang E., Glimelius B. et al. Family History of Hematopoietic Malignancy and Risk of Lymphoma // J. National Cancer Institute. - 2005; 97 (19).
- Dancey J., Cheson B., Chiu B. et al. Update on epidemiology and therapeutics for non-Hodgkin’s lymphoma // Hematology (Am. Soc. Hematol. Educ. Program). - 2002; 241 (62).
- Harris N., Jaffe E., Stein H. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. WHO Classification of Tumours, Vol. 3 IARC WHO Classification of Tumours. - 2001; 3: 351.
- Kari V., Nambiar M., Raghavan S. Chromosomal translocations in cancer // Biochim. Biophys. Acta. - 2008; 2: 139-52.
- Gail M., Goldin L., Gridley G. et al. Familial Aggregation of Hodgkin Lymphoma and Related Tumors // Cancer. - 2004; 100 (9): 1902-8.
- Czene K., Hemminki K., Li X. Familial risk of cancer: data for clinical counseling and cancer genetics // Cancer. - 2004; 108: 109-14.
- Carrington M., Goldstein A., Harty L. et al. HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease // Blood. - 2002; 99: 690-3.
- Hemminki K., Czene K. Attributable risks of familial cancer from the Family-Cancer Database // Cancer Epidemiol. Biomarkers Prev. - 2002; 11: 1638-44.
- Cfan W., Rosenvald A., Wright G. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma // N. Engl. J. Med. - 2002; 364: 1937-47.
- Armitage J., Alizadeh A., Chan W. et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile // Blood. - 2002; 99: 2285-90.